会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Macrocyclic lactams
    • 大环内酰胺
    • US07112581B2
    • 2006-09-26
    • US10673036
    • 2003-09-25
    • Scott C. MitchellBenjamin Nicholson
    • Scott C. MitchellBenjamin Nicholson
    • A61K31/395A61K35/02A61P35/00C07D225/02
    • C07D225/02
    • Compounds represented by the following structure (I), acid-addition salts and pro-drugs are disclosed: wherein the ring structure includes no substitutions, one substitution, or more than one substitution; and wherein n is equal to an integer grater than 1, preferably 2, 3, or 4; m is equal to a positive integer, preferably 1, 2 or 3, and each separate Xn and X are each separately selected from a nucleophilic residue, preferably —H, —OH, —O—CO-alkyl, —O-alkyl, —NH2, a halogen and the like; and wherein the dashed line represents a C—C bond or a C—H bond, and the dashed and solid line represents either a carbon-carbon single bond or a carbon-carbon double bond.
    • 公开了由以下结构(I)表示的化合物,酸加成盐和前药:其中环结构不包括取代,一个取代或多于一个取代; 并且其中n等于1,优选2,3或4的整数倍; m等于正整数,优选1,2或3,并且每个单独的X n和X各自独立地选自亲核残基,优选-H,-OH,-O-CO- 烷基,-O-烷基,-NH 2,卤素等; 并且其中虚线表示C-C键或C-H键,虚线和实线表示碳 - 碳单键或碳 - 碳双键。